InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,488.00
(
0.38%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: bellweather1 post# 2044

Thursday, 09/23/2010 3:41:09 PM

Thursday, September 23, 2010 3:41:09 PM

Post# of 80490
BW,

I haven't been posting as much simply because my position is set and I'm waiting for the ponatinib trial to start, the rida final analysis, and an update on the endometrial trial.

fwiw, I like the ponatinib trial design. Since it's so unique, I would think the FDA had input. imho, it sure seems like the T315I mutation arm was structured in such a way as to allow the for quick approval if the results warrant while allowing the remaining patient groups to continue in the trial.

Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up